David Rimm
Director, Yale Cancer Center Tissue Microarray Facility, Pathology · Yale School of Medicine
Credentials: · · · · · ·
History
PresentPhysician Scientist Training Program, Pathology Research · Yale School of Medicine
- Present
Yale Cancer Center Tissue Microarray Facility · Yale School of Medicine
- Until 1994
Medical College of Virginia
- Until 1993
Research
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
Clinical Cancer Research · 2004 · Last of 3 authors · 3,380 citations
Annals of Oncology · 2015 · 2,547 citations
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Review · Nature Reviews Clinical Oncology · 2021 · 1,282 citations
- RC
75 papers · 6 as a resident
- KS
59 papers
54 papers · 1 as a fellow
32 papers
- RH
30 papers
- JG
20 papers · 6 as a resident
19 papers
- VY
19 papers
Grants
- 1997–2029
- 2020–2026
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
National Institute of Dental and Craniofacial Research · P50
Project lead · $1.1M · Yale University
- 2015–2025
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
National Cancer Institute · P50
Project lead · $3.6M · Yale University
- 2013–2018
(PQC2)High-Content Pathology with Confocal Microscope Arrays
National Cancer Institute · R01
PI · $2.5M · Stanford University
Clinical trials
- 2006–2009
S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313
Principal investigator · Completed
SWOG Cancer Research Network